{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:23:46Z","timestamp":1787160226021,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.humpath.2011.10.022","type":"journal-article","created":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T09:13:18Z","timestamp":1331284398000},"page":"1463-1470","source":"Crossref","is-referenced-by-count":50,"title":["Identification of biomarkers to distinguish clear cell sarcoma from malignant melanoma"],"prefix":"10.1016","volume":"43","author":[{"given":"Linlin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kn\u00f6sel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Geier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Katenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iver","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2011.10.022_bb0005","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/1097-0142(196509)18:9<1163::AID-CNCR2820180916>3.0.CO;2-0","article-title":"Clear-cell sarcoma of tendons and aponeuroses. An analysis of 21 cases","volume":"18","author":"Enzinger","year":"1965","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2011.10.022_bb0010","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/1097-0142(197509)36:3<977::AID-CNCR2820360321>3.0.CO;2-D","article-title":"Clear cell sarcoma with melanin pigment","volume":"36","author":"Bearman","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2011.10.022_bb0015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.5858\/2007-131-152-CCSOTA","article-title":"Clear cell sarcoma of tendons and aponeuroses: a review","volume":"131","author":"Dim","year":"2007","journal-title":"Arch Pathol Lab Med"},{"issue":"Suppl","key":"10.1016\/j.humpath.2011.10.022_bb0020","first-page":"S101","article-title":"Malignant melanoma 2003: predisposition, diagnosis, prognosis, and staging","volume":"120","author":"Carlson","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2011.10.022_bb0025","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMra041245","article-title":"Management of cutaneous melanoma","volume":"351","author":"Tsao","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2011.10.022_bb0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJMra052166","article-title":"Melanoma","volume":"355","author":"Miller","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2011.10.022_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/(SICI)1096-9896(199809)186:1<3::AID-PATH153>3.0.CO;2-V","article-title":"Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) and cutaneous melanoma: exploring the histogenetic relationship between these two clinicopathological entities","volume":"186","author":"Graadt van Roggen","year":"1998","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2011.10.022_bb0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1158\/1078-0432.CCR-10-2276","article-title":"Clinical correlates of NRAS and BRAF mutations in primary human melanoma","volume":"17","author":"Ellerhorst","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2011.10.022_bb0045","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/gcc.2870060412","article-title":"Translocation t(12;22)(q13;q12.2-12.3) in a clear cell sarcoma of tendons and aponeuroses","volume":"6","author":"Mrozek","year":"1993","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2011.10.022_bb0050","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"Pollak","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.humpath.2011.10.022_bb0055","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/modpathol.2009.85","article-title":"Detection and characterization of EWSR1\/ATF1 and EWSR1\/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts)","volume":"22","author":"Wang","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2011.10.022_bb0060","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/path.2132","article-title":"Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) has potential tumour-suppressive activity in human lung cancer","volume":"211","author":"Chen","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2011.10.022_bb0065","first-page":"614","article-title":"Targeting the Raf\/MEK\/ERK pathway with small-molecule inhibitors","volume":"9","author":"McCubrey","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.humpath.2011.10.022_bb0070","first-page":"3728","article-title":"Mitogen-actived protein kinase activation is an early event in melanoma progression","volume":"8","author":"Cohen","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2011.10.022_bb0075","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2011.10.022_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2006.05.002","article-title":"Genetic alterations in melanocytic tumors","volume":"43","author":"Takata","year":"2006","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.humpath.2011.10.022_bb0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.cmr.0000215035.38436.87","article-title":"BRAF somatic mutations in malignant melanoma and melanocytic naevi","volume":"16","author":"Thomas","year":"2006","journal-title":"Melanoma Res"},{"key":"10.1016\/j.humpath.2011.10.022_bb0090","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cancergencyto.2004.04.008","article-title":"Absence of mutations of the BRAF gene in malignant melanoma of soft parts (clear cell sarcoma of tendons and aponeuroses)","volume":"156","author":"Panagopoulos","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.humpath.2011.10.022_bb0095","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/sj.jid.5700026","article-title":"Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma","volume":"126","author":"Goel","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.humpath.2011.10.022_bb0100","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"363","author":"Flaherty","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2011.10.022_bb0105","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2217\/14622416.8.6.597","article-title":"High-resolution DNA melting analysis for simple and efficient molecular diagnostics","volume":"8","author":"Reed","year":"2007","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.humpath.2011.10.022_bb0110","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1471-2407-8-142","article-title":"High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies","volume":"8","author":"Do","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.humpath.2011.10.022_bb0115","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2353\/jmoldx.2009.080100","article-title":"Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumors","volume":"11","author":"Pichler","year":"2009","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.humpath.2011.10.022_bb0120","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1158\/1078-0432.CCR-05-2811","article-title":"EWS-CREB1: a recurrent variant fusion in clear cell sarcoma\u2013association with gastrointestinal location and absence of melanocytic differentiation","volume":"12","author":"Antonescu","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2011.10.022_bb0125","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/modpathol.2008.114","article-title":"Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma","volume":"21","author":"Wang","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2011.10.022_bb0130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/A:1023633704132","article-title":"The role of ATF\/CREB family members in cell growth, survival and apoptosis","volume":"8","author":"Persengiev","year":"2003","journal-title":"Apoptosis"},{"key":"10.1016\/j.humpath.2011.10.022_bb0135","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.1158\/1078-0432.CCR-07-1744","article-title":"EWSR1-CREB1 and EWSR1-ATF1 fusion genes in angiomatoid fibrous histiocytoma","volume":"13","author":"Rossi","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2011.10.022_bb0140","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/PAS.0b013e3181c7d8b2","article-title":"Cutaneous clear cell sarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 12 cases emphasizing its distinction from dermal melanoma","volume":"34","author":"Hantschke","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2011.10.022_bb0145","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/PAS.0b013e31814b18fb","article-title":"Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases","volume":"32","author":"Hisaoka","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2011.10.022_bb0150","doi-asserted-by":"crossref","first-page":"20926","DOI":"10.1073\/pnas.0710359105","article-title":"Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk","volume":"104","author":"Kaneda","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.humpath.2011.10.022_bb0155","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/01.LAB.0000087850.69363.59","article-title":"Genetic and genetic expression analyses of clear cell sarcoma of the kidney","volume":"83","author":"Schuster","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.humpath.2011.10.022_bb0160","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0046-8177(97)90210-0","article-title":"Insulin-like growth factor 2 gene imprinting in clear cell sarcoma of the kidney","volume":"28","author":"Sohda","year":"1997","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2011.10.022_bb0165","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s12094-010-0514-8","article-title":"The insulin-like growth factor pathway as a target for cancer therapy","volume":"12","author":"Lopez-Calderero","year":"2010","journal-title":"Clin Transl Oncol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817711004722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817711004722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,2]],"date-time":"2022-01-02T04:25:37Z","timestamp":1641097537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817711004722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0046817711004722"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2011.10.022","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}